Douglas A Treco Insider Trading $CRSP CRISPR Therapeutics AG
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Douglas A Treco.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Douglas A Treco. Douglas A Treco is President and CEO in Ra Pharmaceuticals, Inc. ($RARX) and Director in CRISPR Therapeutics AG ($CRSP) and Director in Inozyme Pharma, Inc. ($INZY).
Douglas A Treco in CRISPR Therapeutics AG
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Douglas A Treco: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Jun 15 2020
$CRSP Market Capitalization: $605.88M
$CRSP Previous Close: $15.75
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Douglas A Treco in CRISPR Therapeutics AG
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, CRSP, INZY, RARX
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 15 2020 | CRSP | CRISPR Therapeutic ... | Treco Douglas A | Director | Option Exercise | A | 59.70 | 30,000 | 1,791,000 | 30,000 |
Page: 1